Peter Loftus
👤 Speaker
62
total appearances
Appearances Over Time
Podcast Appearances
The Journal.
Ozempic Is a Hit. So Why Is the Drugmaker’s CEO Out?
Shares of Novo Nordisk plunging by the most on record today after disappointing data from its experimental obesity drug.
The Journal.
Ozempic Is a Hit. So Why Is the Drugmaker’s CEO Out?
Shares of Novo Nordisk plunging by the most on record today after disappointing data from its experimental obesity drug.